Systemic Inflammation and Psychiatric Disorders: New Paradigms in Understanding Depression
IOSR Journal of Humanities and Social Science · 2026-06 · 31 (6) · 34-41
DOI: 10.9790/0837-3106053441 ↗Kurz gefasst
Fachartikel in der Zeitschrift IOSR Journal of Humanities and Social Science, 2026-06. Verfasst von Raisa D’ Ricolli Rebouças Rocha und 3 weiteren Autor:innen.
Themen: Depression
Abstract (Originalsprache)
Depression has traditionally been understood as a disorder associated with neurochemical alterations involving neurotransmitters such as serotonin, dopamine, and norepinephrine. However, scientific evidence accumulated over recent decades has indicated that immunological and inflammatory mechanisms have also played a relevant role in its pathophysiology. Chronic low-grade systemic inflammation has been associated with neurobiological alterations capable of influencing brain function, affecting processes related to mood, cognition, motivation, and behavior.
Objective
To analyze the scientific evidence regarding the relationship between systemic inflammation and psychiatric disorders, with emphasis on the new paradigms involved in the understanding of depression and their clinical and therapeutic implications. Methodology: This literature review was conducted in accordance with the recommendations of the PRISMA checklist. Searches were performed in the PubMed, SciELO, and Web of Science databases using scientific articles published within the last 10 years. The descriptors employed were: “Depression,” “Systemic Inflammation,” “Psychiatric Disorders,” “Cytokines,” and “Neuroinflammation.” Inclusion criteria comprised original studies, full-text articles, and research directly related to the association between inflammation and depression. Exclusion criteria included duplicate publications, studies lacking thematic relevance, and articles with insufficiently described methodologies.
Results
The studies analyzed demonstrated a consistent association between elevated inflammatory markers and depressive symptoms. Alterations in the levels of pro-inflammatory cytokines, microglial activation, hypothalamic-pituitary-adrenal axis dysfunction, and impaired neuroplasticity were observed. The findings also indicated that inflammatory processes may contribute to antidepressant treatment resistance and greater symptom severity.
Conclusion
It was concluded that systemic inflammation plays a significant role in the contemporary understanding of depression, expanding explanatory models previously centered solely on neurotransmitters. The evidence analyzed demonstrated that the interaction among immunological mechanisms, neuroinflammation, and neurobiological alterations contributes significantly to the development and progression of the disorder, supporting new diagnostic and therapeutic perspectives in psychiatry.
Zitieren
APA
Rocha, R. D. R. R., Silva, F. D. D., Jaime, D. D. S., & Silva, S. G. R. D. (2026). Systemic Inflammation and Psychiatric Disorders: New Paradigms in Understanding Depression. IOSR Journal of Humanities and Social Science, 31(6), 34-41. https://doi.org/10.9790/0837-3106053441
Vancouver
Rocha RDRR, Silva FDD, Jaime DDS, Silva SGRD. Systemic Inflammation and Psychiatric Disorders: New Paradigms in Understanding Depression. IOSR Journal of Humanities and Social Science. 2026;31(6):34-41. doi:10.9790/0837-3106053441
BibTeX
@article{Rocha2026,
author = {Rocha, Raisa D’ Ricolli Rebouças and Silva, Fernanda Dias da and Jaime, Danielle de Souza and Silva, Samara Galdino Rodrigues da},
title = {Systemic Inflammation and Psychiatric Disorders: New Paradigms in Understanding Depression},
journal = {IOSR Journal of Humanities and Social Science},
year = {2026},
volume = {31},
number = {6},
pages = {34--41},
doi = {10.9790/0837-3106053441}
}
EUVIMED